Wave Life Sciences Ltd.

4.20-0.1500-3.45%Vol 332.89K1Y Perf 20.22%
Dec 2nd, 2022 16:00 DELAYED
BID3.00 ASK4.89
Open4.42 Previous Close4.35
Pre-Market- After-Market4.20
 - -  - -%
Target Price
7.80 
Analyst Rating
Moderate Buy 2.00
Potential %
85.71 
Finscreener Ranking
     40.40
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     33.56
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★+     41.64
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
73.25 
Earnings Rating
Strong Buy
Market Cap364.98M 
Earnings Date
10th Nov 2022
Alpha0.01 Standard Deviation0.28
Beta-0.41 

Today's Price Range

4.094.42

52W Range

1.165.31

5 Year PE Ratio Range

-8.20-3.20

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-0.94%
1 Month
-11.95%
3 Months
47.37%
6 Months
165.82%
1 Year
20.22%
3 Years
-87.68%
5 Years
-89.33%
10 Years
-

TickerPriceChg.Chg.%
WVE4.20-0.1500-3.45
AAPL147.81-0.5000-0.34
GOOG100.83-0.4500-0.44
MSFT255.020.33000.13
XOM109.86-0.9400-0.85
WFC45.94-0.9300-1.98
JNJ178.880.14000.08
FB196.640.99000.51
GE86.881.62001.90
JPM135.16-1.0800-0.79
 
ProfitabilityValueIndustryS&P 500US Markets
-
-3 719.00
-3 475.70
-1 539.50
-
RevenueValueIndustryS&P 500US Markets
4.18M
0.05
36.37
70.75
Earnings HistoryEstimateReportedSurprise %
Q03 2022-0.48-0.4212.50
Q02 2022-0.56-0.62-10.71
Q01 2022-0.56-0.62-10.71
Q04 2021-0.47-0.61-29.79
Q03 2021-0.64-0.1281.25
Q02 2021-0.61-0.78-27.87
Q01 2021-0.56-0.86-53.57
Q04 2020-0.55-0.59-7.27
Earnings Per EndEstimateRevision %Trend
12/2022 QR-0.4027.27Positive
12/2022 FY-1.9911.16Positive
3/2023 QR-0.416.82Positive
12/2023 FY-1.576.55Positive
Next Report Date-
Estimated EPS Next Report-0.48
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume332.89K
Shares Outstanding86.90K
Shares Float63.18M
Trades Count2.68K
Dollar Volume1.41M
Avg. Volume316.84K
Avg. Weekly Volume255.53K
Avg. Monthly Volume356.87K
Avg. Quarterly Volume338.11K

Wave Life Sciences Ltd. (NASDAQ: WVE) stock closed at 4.2 per share at the end of the most recent trading day (a -3.45% change compared to the prior day closing price) with a volume of 332.89K shares and market capitalization of 364.98M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 301 people. Wave Life Sciences Ltd. CEO is Paul B. Bolno.

The one-year performance of Wave Life Sciences Ltd. stock is 20.22%, while year-to-date (YTD) performance is 33.76%. WVE stock has a five-year performance of -89.33%. Its 52-week range is between 1.16 and 5.31, which gives WVE stock a 52-week price range ratio of 73.25%

Wave Life Sciences Ltd. currently has a PE ratio of -2.00, a price-to-book (PB) ratio of 10.21, a price-to-sale (PS) ratio of 93.04, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -80.05%, a ROC of -337.71% and a ROE of -1 204.78%. The company’s profit margin is -%, its EBITDA margin is -3 475.70%, and its revenue ttm is $4.18 Million , which makes it $0.05 revenue per share.

Of the last four earnings reports from Wave Life Sciences Ltd., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.48 for the next earnings report. Wave Life Sciences Ltd.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Wave Life Sciences Ltd. is Moderate Buy (2), with a target price of $7.8, which is +85.71% compared to the current price. The earnings rating for Wave Life Sciences Ltd. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Wave Life Sciences Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Wave Life Sciences Ltd. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.91, ATR14 : 0.45, CCI20 : 40.63, Chaikin Money Flow : -0.22, MACD : 0.01, Money Flow Index : 54.77, ROC : 32.08, RSI : 51.10, STOCH (14,3) : 72.36, STOCH RSI : 0.21, UO : 51.61, Williams %R : -27.64), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Wave Life Sciences Ltd. in the last 12-months were: Chandra Vargeese (Sold 10 603 shares of value $24 599 ), Christopher Francis (Sold 20 990 shares of value $42 075 ), Kyle Moran (Sold 14 225 shares of value $29 897 ), Michael A. Panzara (Sold 27 317 shares of value $53 241 ), Paul B. Bolno (Sold 66 651 shares of value $134 530 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (50.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (50.00 %)
2 (40.00 %)
2 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
1.80
Moderate Buy
1.80

Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.

CEO: Paul B. Bolno

Telephone: +65 62363388

Address: Marina One East Tower, Singapore 018936, , SG

Number of employees: 301

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

56%44%

Bearish Bullish

57%43%

TipRanks News for WVE

Thu, 10 Nov 2022 19:20 GMT Analysts Are Bullish on These Healthcare Stocks: Wave Life Sciences (WVE), Ayr Wellness (AYRWF)

- TipRanks. All rights reserved.

Fri, 23 Sep 2022 04:35 GMT Wave Life Sciences (WVE) Receives a Hold from SVB Securities

- TipRanks. All rights reserved.

Tue, 20 Sep 2022 15:55 GMT Wave Life Sciences (WVE) Receives a Buy from Mizuho Securities

- TipRanks. All rights reserved.

Tue, 20 Sep 2022 15:55 GMT Wave Life Sciences (WVE) Gets a Buy from H.C. Wainwright

- TipRanks. All rights reserved.

Fri, 12 Aug 2022 09:48 GMT Why Is Wave Life Sciences Stock Surging Despite Q2 Miss

- TipRanks. All rights reserved.

News

Stocktwits